Maternal diabetes linked to MS risk in adult children

Credibility

Interest

Share:1 min read

Key Takeaway

Maternal diabetes and larger birth size were linked to higher adult MS risk, while smaller birth size was linked to lower risk.

What They Found

Researchers followed people born in Norway to see whether pregnancy and birth outcomes were linked to MS in adulthood. Those born larger than expected for their stage of pregnancy had a slightly higher MS risk. Those born smaller than expected had a slightly lower MS risk. People whose mothers had diabetes during pregnancy had a higher MS risk. Early birth, placental abruption (when the placenta separates too soon), and high blood pressure during pregnancy were not linked to MS risk.

Who Should Care and Why

The study included people born in Norway between 1967 and 1989. Researchers looked at whether pregnancy and birth outcomes were linked to MS diagnosed in adulthood. This includes people whose mothers had diabetes during pregnancy. It also includes people born smaller or larger than expected for their stage of pregnancy. The findings concern the chance of developing MS, not what happens after an MS diagnosis.

Important Considerations

This study followed 1,166,731 people using Norwegian national records. You cannot tell from this study whether maternal diabetes or birth size caused MS. The researchers reported links with MS risk, not a way to predict who will develop MS.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Living with MS

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like JAMA neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News